| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
23,938 |
22,194 |
$4.34M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
13,438 |
12,223 |
$3.42M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,169 |
8,579 |
$1.76M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,799 |
2,607 |
$458K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
7,400 |
6,687 |
$204K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,685 |
4,019 |
$202K |
| 87428 |
|
2,991 |
2,695 |
$200K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,857 |
7,084 |
$195K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,214 |
1,993 |
$177K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,023 |
1,679 |
$173K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,320 |
19,927 |
$162K |
| 80053 |
Comprehensive metabolic panel |
19,619 |
17,468 |
$159K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,756 |
1,557 |
$145K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
323 |
292 |
$136K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
970 |
918 |
$124K |
| 71046 |
Radiologic examination, chest; 2 views |
2,359 |
2,226 |
$123K |
| 0240U |
|
739 |
676 |
$106K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,692 |
1,612 |
$96K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,893 |
1,716 |
$84K |
| 90836 |
|
2,091 |
1,946 |
$74K |
| 36415 |
Collection of venous blood by venipuncture |
30,603 |
26,319 |
$66K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
292 |
277 |
$61K |
| 71045 |
Radiologic examination, chest; single view |
962 |
862 |
$59K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
55 |
52 |
$55K |
| 70450 |
Computed tomography, head or brain; without contrast material |
138 |
120 |
$55K |
| 90837 |
Psychotherapy, 53 minutes with patient |
969 |
439 |
$50K |
| 83690 |
|
6,020 |
5,404 |
$42K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,590 |
1,408 |
$41K |
| 81005 |
|
18,544 |
16,802 |
$41K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
305 |
285 |
$39K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
472 |
390 |
$33K |
| 81025 |
|
4,144 |
3,789 |
$31K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
398 |
367 |
$30K |
| 84484 |
|
3,144 |
2,553 |
$30K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
887 |
826 |
$27K |
| J3490 |
Unclassified drugs |
2,510 |
1,238 |
$25K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
635 |
591 |
$21K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
621 |
579 |
$20K |
| 83735 |
|
3,357 |
2,914 |
$19K |
| 87800 |
|
279 |
258 |
$17K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
378 |
231 |
$17K |
| 87503 |
|
1,680 |
1,600 |
$17K |
| 90838 |
|
527 |
427 |
$15K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
388 |
375 |
$14K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
27 |
26 |
$13K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,324 |
1,030 |
$12K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
310 |
278 |
$10K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
32 |
27 |
$8K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,352 |
1,199 |
$8K |
| G0378 |
Hospital observation service, per hour |
62 |
37 |
$8K |
| 87390 |
|
291 |
258 |
$7K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
12 |
12 |
$7K |
| 86703 |
|
414 |
379 |
$6K |
| 83880 |
|
241 |
210 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
336 |
303 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,448 |
2,188 |
$5K |
| 86780 |
|
279 |
249 |
$5K |
| 85610 |
|
1,657 |
1,493 |
$5K |
| 87088 |
|
517 |
474 |
$5K |
| 94761 |
|
174 |
159 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
262 |
249 |
$4K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
30 |
26 |
$4K |
| 80061 |
Lipid panel |
223 |
206 |
$3K |
| 59025 |
Fetal non-stress test |
85 |
69 |
$3K |
| 93017 |
|
24 |
24 |
$3K |
| 85027 |
|
280 |
238 |
$2K |
| A9270 |
Non-covered item or service |
1,611 |
731 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
40 |
39 |
$2K |
| 76770 |
|
13 |
12 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
289 |
271 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
32 |
28 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
149 |
137 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
633 |
522 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
616 |
527 |
$1K |
| V2632 |
Posterior chamber intraocular lens |
18 |
14 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
190 |
127 |
$809.41 |
| 86941 |
|
44 |
41 |
$712.33 |
| 86850 |
|
44 |
41 |
$684.93 |
| 86762 |
|
27 |
26 |
$442.30 |
| 84702 |
|
40 |
28 |
$352.02 |
| 87040 |
|
15 |
14 |
$335.49 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
43 |
40 |
$333.50 |
| 85730 |
|
87 |
78 |
$326.95 |
| 84153 |
|
12 |
12 |
$278.54 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
40 |
36 |
$276.26 |
| 87340 |
|
27 |
26 |
$274.84 |
| 82951 |
|
14 |
12 |
$208.52 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
110 |
92 |
$204.51 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
55 |
49 |
$204.02 |
| 82550 |
|
54 |
50 |
$199.03 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
48 |
39 |
$193.41 |
| 83721 |
|
24 |
24 |
$193.14 |
| 86900 |
|
45 |
42 |
$178.82 |
| 86901 |
|
45 |
42 |
$171.40 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
14 |
14 |
$171.36 |
| 87071 |
|
14 |
14 |
$152.75 |
| 83540 |
|
13 |
12 |
$80.80 |
| J2002 |
Injection, lidocaine hcl in 5% dextrose, 1 mg |
14 |
13 |
$73.91 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
47 |
40 |
$54.06 |
| 86592 |
|
14 |
14 |
$53.10 |
| 81000 |
|
14 |
14 |
$39.50 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
12 |
12 |
$32.85 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
14 |
13 |
$29.25 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
32 |
27 |
$14.94 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
14 |
13 |
$7.74 |